Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Dose on Psilocybin Effects
NCT07877987Phase 1Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Mar 2027
- Primary completion
- Jun 2030
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of psilocybin (6 arms), sponsored by Johns Hopkins University. Primary endpoints: Standard Deviation of Lateral Position at 24 hours, Global drive score during the simulated driving task at 24 hours and 5 more. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT07877987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07877987.